Consolidated Balance Sheets - USD ($)	Mar. 31, 2017	Sep. 30, 2016
CURRENT ASSETS
Cash and cash equivalents	$ 61,718,971	$ 85,366,448
Accounts receivable	580,825	75,000
Prepaid expenses	731,834	1,289,923
Other current assets	1,747,801	3,771,172
Short term investments	24,910,492
TOTAL CURRENT ASSETS	89,689,923	90,502,543
Property and equipment, net	15,714,948	15,386,761
Intangible assets, net	21,314,653	22,164,868
Other assets	152,119	122,333
TOTAL ASSETS	126,871,643	128,176,505
CURRENT LIABILITIES
Accounts payable	2,597,889	12,232,906
Accrued expenses	2,184,844	4,587,467
Accrued payroll and benefits	765,292	3,969,706
Deferred rent	440,580	440,580
Deferred revenue	21,169,191	2,569,792
Derivative liabilities	146,178	1,602,626
Note Payable	201,247	194,310
Other current liabilities	46,407	46,407
TOTAL CURRENT LIABILITIES	27,551,628	25,643,794
LONG-TERM LIABILITIES
Deferred rent, net of current portion	2,102,408	2,274,997
Deferred revenue, net of current portion	1,250,000	2,500,000
Note Payable, net of current portion	2,431,118	2,533,455
Other non-current liabilities	200,000	200,000
TOTAL LONG-TERM LIABILITIES	5,983,526	7,508,452
Commitments and contingencies (Note 7)
Arrowhead Pharmaceuticals, Inc. stockholders' equity:
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 0 and 15,652 shares issued and outstanding as of March 31, 2017 and September 30, 2016		16
Common stock, $0.001 par value; 145,000,000 shares authorized; 74,772,103 and 69,746,685 shares issued and outstanding as of March 31, 2017 and September 30, 2016, respectively	167,142	162,116
Additional paid-in capital	510,318,940	493,844,909
Accumulated other comprehensive income (loss)	(30,695)	7,449
Accumulated deficit	(416,563,710)	(398,435,043)
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	93,891,677	95,579,447
Noncontrolling interest	(555,188)	(555,188)
TOTAL STOCKHOLDERS’ EQUITY	93,336,489	95,024,259
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 126,871,643	$ 128,176,505

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Name:	us-gaap_AccountsPayableCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.